Type 2 Diabetes Mellitus
Conditions
Interventions
Trail group:None
Sponsors
Dongying People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged at least 18 years of age; 2. A diagnosis of type 2 diabetes and course within 5 years; 3.GADA and other type 1 diabetes-related antibodies are negative; 4. Fasting blood glucose between 7.0-11.0mmol/L, HbA1c above 7.0%, fasting C-peptide =1.1µg/L, BMI>25kg/m2; 5. Combination of metformin, SGLT2i(dapagliflozin/empagliflozin/constagliflozin/itogagliflozin/canagliflozin) and GLP-1RA(loseenatide/semaglutide/duraglutide/liraglutide) was newly used in the past 3 months and currently used regularly to control blood glucose; 6. Are receiving diabetes related lifestyle guidance; 7. Willing to participate in the study and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. With type 1 diabetes, gestational diabetes, or other special types of diabetes; 2. There are serious heart, liver, kidney, nerve, blood or endocrine system diseases; 3. There are serious infection, trauma, surgery, or other irritability disease; 4. Severe gastrointestinal disease or malabsorption syndrome; 5. Severe mental illness or cognitive impairment; 6. A history of acute pancreatitis, urinary tract or genital infection; 7. Any kind of drugs in the 221 plan the composition of the allergy or intolerance. 8. Use of other glucose-lowering medications or participation in other clinical trials within the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| glycated hemoglobin; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood biochemical indicators;liver function;blood lipid profile;insulin;C-peptide;routine urine test;urinary albumin;body mass index;Chinese Visceral Adiposity Index(CVAI);Fatty liver degree;Muscle content; | — |
Countries
China
Contacts
Public ContactXu Chao
Dongying People's Hospital
Outcome results
None listed